US Stock MarketDetailed Quotes

ALDX Aldeyra Therapeutics

Watchlist
  • 5.270
  • -0.180-3.30%
Close Jan 6 16:00 ET
  • 5.270
  • 0.0000.00%
Post 16:37 ET
313.83MMarket Cap-7.03P/E (TTM)

Aldeyra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aldeyra Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 0.000 --
-- 2024/Q4 -- / 0.000 --
-- 2024/Q3 0.000 / 0.000 --
-- 2024/Q2 0.000 / 0.000 --
-- 2024/Q1 0.000 / 1.000M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 1.000M--

Unlock Free Earnings Estimates

Aldeyra Therapeutics Earnings Reports

  • Aldeyra Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 8, 2024 05:04

  • Aldeyra Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 2, 2024 04:10

  • Aldeyra Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 3, 2024 04:10

  • Aldeyra Therapeutics | 10-K: FY2023 Annual Report

    Mar 8, 2024 05:10

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 3, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data